Observational studyCurrent neuropharmacology2026

Blockade of Interleukin-6 Receptor with Tocilizumab During the Acute Phase of Childhood Immune-Mediated Epilepsy can Lead to a Favorable Outcome - an Observational Study.

Xiaolu Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.